We’re #hiring. Know anyone who might be interested?
Spirair
Medical Equipment Manufacturing
South San Francisco, CA 2,251 followers
Pioneering minimally invasive therapies for ENTs to help more patients breathe better
About us
Spirair is an early-stage company pioneering minimally invasive solutions that help ENTs advance care for their patients by providing strong outcomes and a better patient experience. We’re committed to developing new therapies that can easily integrate in any ENT’s treatment algorithms so they can help more of their patients breathe better. Spirair got its start in the Stanford Biodesign Innovation Fellowship, a program that equips aspiring innovators with a proven, repeatable process to identify important health-related needs, invent novel health technologies to address them, and prepare to implement those products into patient care. Founders James Kintzing, Ph.D. and Brandon McCutcheon, M.D. were co-fellows in the program and identified an opportunity in the ENT space when they discovered the unmet need for a minimally invasive nasal septal deviation correction therapy to help address nasal airway obstruction. Our first product is a novel solution for symptomatic nasal septal deviation (NSD) that supports and straightens minor deviations in the septal cartilage. The procedure can be conveniently and safely performed under local anesthesia or in any site of service as part of standard septoplasty techniques.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
South San Francisco, CA, US
Employees at Spirair
Updates
-
Thank you from all of us at Spirair for connecting at the recent American Rhinologic Society and American Academy of Otolaryngology annual meetings! We enjoyed meeting physicians from around the world, reconnecting with old friends, and contributing to important conversations about advancing ENT technology. A special highlight— our CEO, Benjamin Bishop, presented at the inaugural AAO Innovation Connection Panel alongside leaders in the field. Missed us in Indy? Feel free to reach out and we will find a way to connect, either virtually or in person. #OTOMTG25 #ENT #AAOHNSF #MedTech #SeptAlign #TurbAlign
-
-
👋 We’re excited to kick off the American Academy of Otolaryngology AAO-HNSF annual meeting! Come visit us at our booth in the Innovation Park area of the Expo Hall—we’d love to connect. #OTOMTG25 #ENT #AAOHNSF #MedTech #SeptAlign #TurbAlign
-
-
Congratulations to Chris Davis, MD on being the first physician in the U.S. to use TurbAlign commercially! We’re honored to work closely with pioneers like Dr. Davis who are helping bring new solutions to ENT patients. Want to learn more about TurbAlign? Visit spirair.com/turbalign or -better yet- stop by the Spirair booth at the upcoming ARS and AAO-HNSF annual meetings in Indianapolis! #OTOMTG25 #ENT #AAOHNSF #MedTech #TurbAlign
-
-
We’re thrilled to welcome Paul Praino as Spirair’s new Vice President of Sales! Paul brings over 17 years of experience in medical device sales and a strong track record of successfully commercializing innovative healthcare technologies. His passion for building high-performing teams and driving growth makes him an incredible addition to our leadership team. Paul’s especially excited to return to the ENT specialty and help lead Spirair into its next stage of expansion. Welcome aboard, Paul - we can’t wait to see the impact you’ll make!
-
-
We’re looking forward to connecting at the upcoming American Rhinologic Society and American Academy of Otolaryngology AAO-HNSF annual meetings in Indianapolis! If you’ll be there, we’d love to connect – be sure to reach out to find a time to meet, or simply stop by our booth to say hello. #OTOMTG25 #ENT #AAOHNSF #MedTech #SeptAlign #TurbAlign
-
-
We are excited to announce FDA Clearance for our latest product: TurbAlign™ TurbAlign is a novel bioabsorbable implant that helps keep sinonasal passages open during the critical healing period after sinus surgery. It’s inserted with a simple, one-pass, knot-free technique, then resorbs without the need for removal. “Our expanding portfolio highlights our commitment to ENT solutions that enhance patient care,” said Benjamin Bishop, CEO of Spirair. “TurbAlign provides a novel approach to middle turbinate medialization, while SeptAlign™ targets septal deviation. Together, they provide complementary advancements in nasal and sinus surgery.” U.S. availability is expected later this year. Read the full press release: http://bit.ly/3TTDOsO #FDAcleared #TurbAlign #Spirair #SinusSurgery #MedTech #ENT #Otolaryngology
-
-
Exciting Milestone for SeptAlign™ ! We’re proud to announce the first clinical publication evaluating our SeptAlign™ implant. The 12-month outcomes show promising safety and efficacy for this novel, minimally invasive device, which offers a cartilage-sparing approach to traditional septoplasty for the treatment of nasal septal deviation. · 71.8% median improvement in NOSE scores · 60.3% median improvement in SNOT-22 scores · Rapid relief observed within one month We’re sincerely grateful to the study investigators and the entire clinical team for their leadership and support. With additional studies already underway, we’re excited to continue building the clinical foundation for SeptAlign and advancing ENT care. Read the full press release: http://bit.ly/3FR6W0p Learn more: septalign.com #ENT #Septoplasty #NasalObstruction #Spirair #SeptAlign #Medtech #ClinicalInnovation #Biodesign